Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 29, 2018	Sep. 29, 2017
Current assets:
Cash and cash equivalents	$ 829,621	$ 627,017
Restricted cash	7,842	7,351
Short-term investments	195,284	247,757
Accounts receivable, net of allowance for doubtful accounts of $5,622 and $2,967	149,582	73,750
Inventories	23,932	25,051
Prepaid expenses and other current assets	32,672	30,508
Total current assets	1,238,933	1,011,434
Long-term investments	243,179	314,364
Property, plant, and equipment, net	502,041	485,275
Intangible assets, net	185,140	189,648
Goodwill	314,317	311,087
Deferred taxes	143,949	190,915
Other non-current assets	42,260	30,831
Total assets	2,669,819	2,533,554
Current liabilities:
Accounts payable	16,970	14,373
Accrued liabilities	197,076	207,034
Income taxes payable	4,830	1,216
Deferred revenue	21,436	23,150
Total current liabilities	240,312	245,773
Long-term deferred revenue	37,775	36,425
Other non-current liabilities	203,813	107,514
Total liabilities	481,900	389,712
Stockholders’ equity:
Additional paid-in capital	89,077	61,331
Retained earnings	2,105,621	2,083,063
Accumulated other comprehensive (loss)	(13,301)	(7,753)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,181,500	2,136,742
Controlling interest	6,419	7,100
Total stockholders’ equity	2,187,919	2,143,842
Total liabilities and stockholders’ equity	2,669,819	2,533,554
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 64,077,013 shares issued and outstanding at June 29, 2018 and 59,281,837 at September 29, 2017
Stockholders’ equity:
Common stock	60	58
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 39,511,036 shares issued and outstanding at June 29, 2018 and 42,873,597 at September 29, 2017
Stockholders’ equity:
Common stock	$ 43	$ 43